IRIS
Franzese, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.589
AS - Asia 5.768
EU - Europa 2.038
SA - Sud America 1.411
AF - Africa 274
Continente sconosciuto - Info sul continente non disponibili 235
OC - Oceania 26
Totale 20.341
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.354
SG - Singapore 3.432
BR - Brasile 1.136
CN - Cina 985
VN - Vietnam 665
IT - Italia 508
FI - Finlandia 298
DE - Germania 297
IE - Irlanda 235
HK - Hong Kong 173
NG - Nigeria 154
GB - Regno Unito 133
FR - Francia 128
CA - Canada 124
IN - India 110
AR - Argentina 103
NL - Olanda 88
SE - Svezia 85
BD - Bangladesh 61
RU - Federazione Russa 58
EC - Ecuador 46
MX - Messico 45
ID - Indonesia 43
TR - Turchia 43
CO - Colombia 39
ZA - Sudafrica 34
IQ - Iraq 33
ES - Italia 29
IL - Israele 28
VE - Venezuela 28
PL - Polonia 27
CL - Cile 26
AU - Australia 25
UA - Ucraina 25
BE - Belgio 23
UZ - Uzbekistan 22
PK - Pakistan 19
SA - Arabia Saudita 18
AT - Austria 16
JP - Giappone 16
MA - Marocco 16
KE - Kenya 14
PY - Paraguay 14
EG - Egitto 13
RO - Romania 13
CZ - Repubblica Ceca 12
TN - Tunisia 12
MY - Malesia 11
PE - Perù 11
AZ - Azerbaigian 10
DZ - Algeria 10
HN - Honduras 10
KZ - Kazakistan 10
LT - Lituania 10
NP - Nepal 10
OM - Oman 10
PH - Filippine 10
JO - Giordania 9
AE - Emirati Arabi Uniti 8
GT - Guatemala 7
JM - Giamaica 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
BG - Bulgaria 6
CR - Costa Rica 6
IR - Iran 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NO - Norvegia 5
RS - Serbia 5
SV - El Salvador 5
BO - Bolivia 4
GE - Georgia 4
HR - Croazia 4
SN - Senegal 4
AM - Armenia 3
BB - Barbados 3
BS - Bahamas 3
CH - Svizzera 3
CI - Costa d'Avorio 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
DK - Danimarca 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
SI - Slovenia 2
Totale 20.085
Salva come PNG Salva come JPEG
Città #
Singapore 1.519
Wilmington 1.085
Dallas 983
Chandler 761
Ashburn 627
San Jose 592
The Dalles 477
San Mateo 411
Shanghai 403
Helsinki 296
Council Bluffs 294
Ann Arbor 287
Beijing 243
Dublin 234
Ho Chi Minh City 232
Princeton 213
Leawood 198
Boardman 196
Lawrence 187
Milan 185
New York 180
Hanoi 157
Santa Clara 157
Benin City 153
Hong Kong 148
Woodbridge 122
Falkenstein 118
Los Angeles 112
Fairfield 107
São Paulo 102
Paris 96
Phoenix 78
Amsterdam 70
Buffalo 65
Rome 63
London 54
Rio de Janeiro 44
Seattle 44
Toronto 43
Chicago 36
Orem 34
Da Nang 32
Norwalk 28
San Diego 28
Belo Horizonte 27
Chennai 27
Haiphong 27
Brooklyn 26
Figino 25
Kocaeli 25
Miami 25
Philadelphia 24
Naples 23
Charlotte 22
Montreal 22
Brussels 20
Porto Alegre 20
Warsaw 20
Atlanta 19
Brasília 19
Tashkent 18
Boston 17
Guayaquil 17
Mexico City 17
Milwaukee 17
The Bronx 17
Curitiba 16
Fortaleza 16
Monmouth Junction 16
Munich 16
Tokyo 16
Denver 15
Johannesburg 15
Queens 15
Can Tho 14
Frankfurt am Main 14
Manchester 14
Columbus 13
Houston 13
Jacksonville 13
Moscow 13
Ribeirão Preto 13
San Francisco 13
Baghdad 12
Biên Hòa 12
Des Moines 12
Dhaka 12
Hải Dương 12
Memphis 12
Pune 12
Bogotá 11
Hillsboro 11
Nairobi 11
Quito 11
Stockholm 11
Madrid 10
Ninh Bình 10
Oakland 10
Salvador 10
Santo André 10
Totale 12.402
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 769
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 159
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 156
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 140
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 133
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 128
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 128
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 126
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 125
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 124
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 120
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 119
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 115
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 115
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 115
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 112
Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: a single centre experience 111
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 111
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 110
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 110
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 109
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 108
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 104
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 103
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach 103
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 101
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 100
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 100
Hypofractionated stereotactic radiation therapy in skull base meningiomas 99
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 99
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy 98
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 97
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 96
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 95
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 94
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 94
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 93
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 91
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 91
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 91
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO‐Head and Neck working group 90
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 90
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 90
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 89
Imaging biomarkers in primary brain tumours 89
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 89
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-years toxicity and clinical results 88
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 88
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 88
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 88
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 87
Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis 86
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 85
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 85
Efficacy and safety of re-irradiation of locally recurrent prostate cancer with FFF-VMAT 85
Phase II trial of hypofractionated VMAT for early stage breast cancer: Acute toxicity and cosmetic results in 840 patients 85
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 84
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 84
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 84
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 83
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 83
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 83
Critical re-evaluation of a failure mode effect analysis in a radiation therapy department after ten years 83
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 82
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 82
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 81
Results of a feed-back learning process for RapidPlan knowledge based planning 81
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome 81
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 80
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 80
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 79
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 79
RapidPlan head and neck model: the objectives and possible clinical benefit. 79
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 79
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 79
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 79
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 79
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 79
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer 78
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 78
SBRT for oligometastatic gynecological cancer: a single institution experience 78
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 78
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 78
Role of SBRT with VMAT-FFF for abdomino-pelvic lymph node metastases in oligometastatic patients 78
Role of C-11-CHOLINE PET/CT in the Radiotherapy Treatment Planning of Prostate Cancer Patients 78
Low Prevalence of K-RAS, EGF-R and BRAF Mutations in Sinonasal Adenocarcinomas. Implications for Anti-EGFR Treatments 78
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality 78
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 78
Radiotherapy and Immunotherapies in elderly: a systematic literature review 78
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity 78
Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question 77
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 77
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 77
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 77
LINAC-BASED STEREOTACTIC RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW-UP UPDATE ON TOXICITY AND SURVIVAL 77
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 77
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 77
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 76
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 76
Stereotactic Body Radiation Therapy for oligometastatic patients with ovarian cancer 76
Totale 9.980
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022906 0 0 0 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.463 72 167 327 80 45 145 58 70 70 32 152 245
2024/20252.459 51 89 33 33 23 276 121 226 381 644 254 328
2025/20268.314 1.025 610 1.003 1.060 214 289 1.819 559 434 431 283 587
2026/20272.792 533 642 1.217 400 0 0 0 0 0 0 0 0
Totale 20.341